US SEC Filings Daily Market Digest — September 22, 2026

22-09-2026

On Holding AG filed a Form 6-K on September 22, 2026, announcing its three-year financial outlook at an Investor Day meeting. The filing provides forward-looking guidance but does not disclose specific financial figures or performance metrics. No prior-period comparisons or detailed quantitative data are included in this filing.

• · The filing is a Form 6-K for the month of September 2026.
• · The company's address is Förrlibuckstrasse 190, 8005 Zurich, Switzerland.
• · The filing was signed by CFO Frank Sluis on September 22, 2026.

22-09-2026

Elmet Group Co. entered into a warrant purchase agreement with Blue Moon Metals Inc. on September 21, 2026, issuing an unregistered warrant to purchase up to 1,166,970 shares of common stock at an exercise price of $21.423 per share. The warrant becomes exercisable six months after issuance and expires in three years. The transaction was conducted under an exemption from registration under the Securities Act.

• · The warrant is exercisable on a cashless basis if no effective registration statement is available for resale of the warrant shares.
• · The holder may increase or decrease the beneficial ownership limitation up to 19.99% at its election.
• · In a fundamental transaction, the holder receives the same consideration as if it held the warrant shares immediately prior to the transaction.
• · The warrant was issued under Section 4(a)(2) of the Securities Act; shares upon exercise will rely on Section 3(a)(9) or 4(a)(2).

22-09-2026

Cadeler A/S, through its Nexra platform, has signed a non-binding MoU with Vattenfall to jointly explore next-generation O&M solutions for offshore wind, focusing on Major Component Exchange (MCE) capabilities. The collaboration aims to improve efficiency, safety, and scalability of maintenance activities across multiple turbine platforms. No financial terms or binding commitments were disclosed, and the initiative is exploratory in nature.

• · Nexra is Cadeler’s dedicated O&M service platform, established in 2025.
• · The MoU is non-binding and exploratory, with no financial terms or binding commitments disclosed.
• · The collaboration focuses on improving efficiency, safety, and scalability of offshore wind maintenance activities across multiple turbine platforms.

22-09-2026

Aurora Mobile Ltd filed its unaudited consolidated interim financial statements for the six months ended June 30, 2026, via a Form 6-K with the SEC. The filing includes balance sheet, income statement, and cash flow data for the current and prior periods, as well as segment information for subscription services, value-added services, and vertical applications. No specific financial figures or narrative commentary are provided in the filing text itself, only references to the attached exhibit.

• · The filing is incorporated by reference into the company's Form F-3 registration statements (File Nos. 333-290371 and 333-294664).
• · The report covers the period January 1, 2026 to June 30, 2026.
• · Segment data includes Subscription Services, Value-Added Services, and Vertical Applications.
• · The company has four incentive plans: 2014, 2017, 2021, and 2023.
• · Cash is concentrated in China and outside China.

22-09-2026

Pioneer Power Solutions, Inc. filed definitive additional proxy materials (DEFA14A) with the SEC on September 22, 2026, in connection with its upcoming annual meeting. The filing indicates no fee is required and does not contain specific financial results or operational updates.

• · Filing is definitive additional materials (not preliminary or definitive proxy statement).
• · No fee required for the filing.
• · Filed by the registrant (Pioneer Power Solutions, Inc.).

22-09-2026

Valens Semiconductor Ltd. entered into a license agreement with onsemi to grant a non-exclusive license for its MIPI A-PHY connectivity technology, enabling onsemi to produce a cost-optimized 3MP integrated image sensor for high-volume automotive camera applications. The agreement, signed September 14, 2026, includes royalty payments to Valens and can be terminated after ten years for convenience with 180 days' notice, with license survival for products already on the roadmap. The collaboration strengthens the A-PHY ecosystem and broadens Valens' market reach, but no specific financial terms or revenue guidance were disclosed.

• · The license agreement grants onsemi a non-exclusive right to make and sell a next-generation integrated image sensor product incorporating Valens' MIPI A-PHY technology.
• · The agreement is effective as of September 14, 2026 and can be terminated after ten years for convenience upon 180 days' prior written notice, or earlier upon material breach.
• · Upon termination, the license survives for products already on onsemi's product roadmap or commercialized prior to termination, subject to continued royalty payments.
• · The collaboration targets high-volume 3MP automotive camera applications, addressing the 1-3MP majority of automotive image sensors and providing an upgrade path to higher resolutions.
• · No specific royalty rates, upfront payments, or revenue guidance were disclosed in the filing.

22-09-2026

Host Digital Inc. filed an amendment (8-K/A) to correct the name of an underwriter in the underwriting agreement related to a September 17, 2026 offering. The filing does not contain any financial results or new business developments; it is a clerical correction only.

• · The amendment corrects the name of one underwriter from 'Siebert Williams Shank & Co, LLC' to 'Muriel Siebert & Co., LLC' in Schedule A of the Underwriting Agreement.
• · The original Form 8-K was filed on September 21, 2026; this amendment was filed on September 22, 2026.
• · No other information in the original filing is amended, updated, or modified.

22-09-2026

Wise Group plc repurchased Class A ordinary shares on multiple venues (XLON, NASDAQ, CHIX, BATE) between September 14-18, 2026, as part of its buyback program. Total shares purchased across all venues and dates were approximately 1,887,474 shares, with prices ranging from GBP 8.5740 to GBP 9.0580 on UK/European venues and USD 11.4950 to USD 12.2250 on NASDAQ. The buyback reflects ongoing capital return to shareholders, though the share price showed a slight downward trend over the week (e.g., XLON VWAP declined from GBP 8.9921 to GBP 8.6961).

• · Daily purchase volumes varied significantly by venue; e.g., on 2026-09-15, 200,000 shares were bought on NASDAQ at an average of USD 11.7338, while on 2026-09-18 only 34,955 shares were bought on BATE at GBP 8.6974.
• · Highest price paid during the period was GBP 9.0580 (XLON, 2026-09-14) and USD 12.2250 (NASDAQ, 2026-09-14); lowest was GBP 8.5740 (XLON, 2026-09-16) and USD 11.4950 (NASDAQ, 2026-09-18).
• · The buyback was executed across four trading venues: XLON, NASDAQ, CHIX, and BATE.

22-09-2026

Equinor ASA disclosed transactions under the third tranche of its 2026 share buy-back programme, covering the week of September 14-18, 2026. During this period, the company repurchased 535,701 shares on the Oslo Stock Exchange (OSE) at a weighted average price of NOK 419.4578, for a total value of NOK 224,703,937.14. The accumulated buy-backs under the tranche now total 5,567,791 shares at a weighted average price of NOK 393.3827, representing NOK 2,190,272,928.71. The buy-back activity is part of the company's ongoing capital return programme.

• · Daily weighted average share price ranged from NOK 415.3517 (Sep 18) to NOK 423.8777 (Sep 16).
• · Daily transaction values ranged from NOK 55,707,418.80 (Sep 14) to NOK 56,799,611.80 (Sep 16).
• · No transactions were reported on CEUX or TQEX venues during the period.
• · The weighted average price for the period (NOK 419.4578) was higher than the accumulated average (NOK 393.3827), indicating recent purchases were at higher prices.

22-09-2026

ING Groep N.V. filed a Form 6-K with the SEC on September 22, 2026, reporting the issuance of a press release on the same date. The filing is a routine foreign private issuer disclosure under Rule 13a-16, with no financial results or material operational updates included in the provided content.

• · Filing date: September 22, 2026
• · Commission File Number: 001-14642
• · Exhibit 99.1: Press release dated September 22, 2026, incorporated by reference

22-09-2026

New Oriental Education & Technology Group Inc. filed its annual report (20-F) for the fiscal year ended May 31, 2026, reporting total net revenues of $5,661.3M, up 15.5% from $4,900.3M in FY2025. Net income attributable to shareholders grew 27.8% to $475.2M from $371.7M, driven by strong service revenue growth. However, net product revenues declined 30.3% year-over-year to $768.3M, and interest income fell 35.7% to $76.9M, partially offsetting the gains.

• · Diluted EPS for FY2026 was $0.30, unchanged from basic EPS, compared to $0.23 diluted EPS in FY2025.
• · Share buyback reduced weighted average basic shares from 1,619.7M in FY2025 to 1,578.5M in FY2026, a 2.5% decline.
• · Total operating costs and expenses rose 12.2% YoY to $5,018.0M in FY2026 from $4,472.0M in FY2025.
• · Selling and marketing expenses increased 9.2% YoY to $855.9M in FY2026.
• · General and administrative expenses increased 10.4% YoY to $1,594.0M in FY2026.
• · Impairment of goodwill was $60.3M in FY2025 but zero in FY2026.
• · Loss from equity method investments was $17.8M in FY2026, up from $14.3M in FY2025.
• · Non-controlling interests net income was $41.5M in FY2026, up from $4.1M in FY2025.
• · Total equity grew 9.4% to $4,324.4M as of May 31, 2026 from $3,953.7M a year earlier.
• · Current liabilities increased 18.2% to $3,889.7M as of May 31, 2026.
• · The company's effective tax rate increased, with provision for income taxes rising 34.1% YoY.

22-09-2026

Senti Biosciences Holdings, Inc. filed Amendment No. 3 to its Form S-3 registration statement on September 22, 2026, solely to include an updated auditor consent from KPMG LLP. The shelf registration, originally filed on September 10, 2026, covers the potential offering of securities on a delayed or continuous basis. No new financial data or business updates were provided in this filing.

• · The filing is an exhibits-only amendment to include an updated auditor consent (Exhibit 23.1).
• · The registration statement number is 333-296917.
• · The company is a non-accelerated filer, smaller reporting company, and emerging growth company.
• · The company has elected not to use the extended transition period for complying with new or revised financial accounting standards.
• · The filing references several recent transactions: a merger agreement dated April 24, 2026, a securities purchase agreement dated April 27, 2026, and a merger agreement dated July 14, 2026 involving Celadon Partners SPV 35 Limited.
• · An equity commitment letter from CPIF II-9 Limited dated September 3, 2026 is included as an exhibit.

22-09-2026

Pharming announced positive topline data from a Phase II trial of leniolisib in patients with primary immunodeficiencies (PIDs) with immune dysregulation, showing clinical improvements including a mean 26.4% spleen volume reduction. The data was accepted as a late-breaking abstract at ESID 2026. However, the trial enrolled only 13 patients, and the safety profile showed infections as the most common events, with no new safety signals. Pharming expects to report topline results from a separate Phase II trial in CVID in Q4 2026.

• · Leniolisib is approved as the first and only targeted treatment for APDS in multiple regions, including the U.S., EU, and Japan.
• · The Phase II trial is single-arm, open-label, intra-patient dose-escalation, evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy.
• · Clinical improvements included reductions in lymphoproliferative disease and size of index lesions.
• · Safety observations were consistent with the known safety profile of leniolisib; infections were the most common events, with no new safety signals.
• · The abstract will be presented at ESID 2026, taking place October 14-17 in the Netherlands.
• · Pharming expects to report Phase II results for leniolisib in CVID patients in Q4 2026, which will inform plans for a potential registrational study in the broader CVID population.

22-09-2026

Here Group Ltd reported Q4 FY2026 revenues of RMB127.7M (US$18.8M), a 94.1% YoY increase but a 22.5% sequential decline from Q3 FY2026, indicating slowing momentum. The company posted a net loss of RMB169.6M (US$25.0M) for the quarter, significantly wider than losses in both prior periods, largely due to a RMB124.1M goodwill impairment. For the full year FY2026, revenues reached RMB596.8M (US$88.0M), the first full year of pop toy business revenue versus RMB65.8M in FY2025, while adjusted net loss widened to RMB93.9M (US$13.8M) from RMB19.3M, highlighting ongoing profitability challenges.

• · Q4 FY2026 revenue of RMB127.7M declined 22.5% sequentially from Q3 FY2026 due to slowing quarterly momentum.
• · Full year FY2026 revenue of RMB596.8M represents the first full year of revenue from the pop toy business, compared to RMB65.8M in FY2025.
• · Q4 net loss of RMB169.6M included a RMB124.1M goodwill impairment; without this, adjusted net loss was RMB37.7M.
• · FY2026 net loss widened to RMB254.9M from RMB21.8M in FY2025, driven by the goodwill impairment and other costs.

22-09-2026

SUPER HI INTERNATIONAL HOLDING LTD. filed its 2026 Interim Report as a Form 6-K with the SEC on September 22, 2026, covering the period ended June 30, 2026. The filing, signed by Director and Chairperson Ping Shu, provides interim financial results and operational updates for the Singapore-based company. No specific financial figures were disclosed in the filing summary, limiting quantitative analysis.

• · Filing date: September 22, 2026
• · Commission File Number: 001-42101
• · Interim report covers the six months ended June 30, 2026
• · Company address: 1 Paya Lebar Link, #09-04 PLQ 1 Paya Lebar Quarter, Singapore 408533

22-09-2026

IMMUTEP Limited filed a Form 6-K with the SEC on September 22, 2026, disclosing a change to its American Depositary Share (ADS) ratio. The filing was signed by CEO Marc Voigt and contains no financial results or material operational updates.

• · The filing is a routine report of a foreign private issuer under Rule 13a-16 or 15d-16.
• · The only substantive disclosure is a change to the American Depositary Share ratio (details not provided in the filing).
• · No financial data, operational metrics, or forward-looking statements were included.

22-09-2026

BBVA disclosed transactions under the first tranche of its share buyback program, conducted between September 14 and September 18, 2026. Through these purchases, the aggregate cash amount spent reached €814,322,682.18, representing 81.43% of the maximum cash amount allocated for the first tranche. The filing confirms ongoing execution of the buyback announced on July 30, 2026.

• · The first tranche manager is HSBC Continental Europe.
• · Transactions occurred during the trading week of September 14–18, 2026.
• · The maximum cash amount of the first tranche is implied to be approximately €1.0 billion (since 81.43% of the maximum equals €814M).
• · Own shares repurchased under the program are intended to be cancelled or used for employee compensation (per the original announcement on July 30, 2026).
• · The filing is a routine update; no performance metrics or period-over-period comparisons are provided.

22-09-2026

Caledonia Mining Corporation Plc filed a Form 6-K with the SEC on September 22, 2026, covering a press release dated the same day. The filing is a routine foreign issuer report and contains no specific financial performance data or material events.

• · The filing references a press release (Exhibit 99.1) dated September 22, 2026, but the full text is not included in the filing.

22-09-2026

DigitalBridge Group, Inc. filed Form 25 with the SEC on September 22, 2026, to voluntarily withdraw its 7.125% Series H, I, and J Cumulative Redeemable Preferred Stock from listing and registration on the New York Stock Exchange. The company certifies it has met all exchange and SEC requirements for the voluntary delisting. No financial figures or performance metrics are provided in this filing.

• · The delisting is voluntary under 17 CFR 240.12d2-2(c).
• · The filing covers three series of preferred stock: Series H, I, and J, each with a 7.125% coupon and $0.01 par value.
• · The effective date of the filing is September 22, 2026.

22-09-2026

Immuron Ltd (NASDAQ: IMRN) presented at the Coffee Microcaps Conference on September 22, 2026, highlighting its strategic reset toward profitability and reduced cash burn. FY26 global sales revenue grew 6% to A$7.7M, with Australian sales up 10% to A$5.8M and U.S. sales up 7% to A$1.8M (13% in USD). However, gross profit margin declined 0.9% to 64.5%, and the company reported a net loss of A$3.8M, though this improved by A$1.4M year-over-year. Cash stood at A$9.0M (down from A$15.2M a year earlier, a 41% decline), providing a 24-month runway. The company is actively seeking partners for its two clinical assets, IMM-124E (Travelan) and IMM-529, with Lumanity peak U.S. sales estimates of US$102M and US$400M, respectively.

• · IMM-529 is a first-in-class triple-action CDI biologic targeting Toxin B, vegetative cells, and spores; pre-clinical efficacy showed ~80% prevention, ~80% treatment, and ~90% relapse survival rates.
• · IMM-529 has FDA IND approval and is ready for Phase 2 clinical trials.
• · Travelan (IMM-124E) is eligible for an end-of-Phase 2 meeting with the FDA for traveler's diarrhea indication.
• · Immuron executed an exclusive distribution agreement for ProIBS in the United States in September 2026.
• · The company engaged Pullan Consulting to support partnering of IMM-529.
• · Cash burn reduction is expected from lower R&D expenses (net of R&D Tax Incentive).
• · The company's market cap was A$14.85M as of 17 September 2026, with a 52-week high/low of A$0.098/0.026 on ASX and $2.39/$0.6765 on NASDAQ.
• · Last traded price on ASX was A$0.046.
• · The Australian IBS treatment market is estimated at AU$221.14M in 2025 with 3.28% annual growth (Statista).

22-09-2026

abrdn Global Infrastructure Income Fund (ASGI) filed an 8-K on September 22, 2026, disclosing a rights offering with a guaranteed delivery notice. The offering, detailed in a Prospectus Supplement dated September 21, 2026, allows shareholders to subscribe for common shares under a primary subscription and over-subscription privilege, with an expiration date of October 15, 2026. The filing is procedural, providing instructions for guaranteed delivery and payment, with no financial results or performance data included.

• · Expiration Date for guaranteed delivery: October 15, 2026, 5:00 p.m. Eastern time
• · Subscription certificates must be delivered by the close of business on the first business day after the Expiration Date
• · Guaranteed delivery of subscription certificates required by 5:00 p.m. Eastern time on the second business day after the Expiration Date
• · Rights exercise ratio: 1 Right per 3 Common Shares (Rights ÷ by 3)
• · Subscription Agent: Equiniti Trust Company, LLC, with toll-free phone (877) 248-6417

22-09-2026

Black Hawk Acquisition Corp (SPAC) filed a 424B4 proxy/prospectus for an extraordinary general meeting on October 13, 2026, to approve its business combination with Vesicor Therapeutics, which will result in PubCo renaming to Vesicor Therapeutics Holdings, Inc. and relisting under a new Nasdaq ticker. The deal values Vesicor at an Equity Value of $70,000,000, with PubCo issuing shares and assuming warrants. However, Black Hawk breached extension payment obligations in November and December 2025 (and initially January 2026), making late payments after cure periods expired, which could have triggered liquidation; the company avoided liquidation but acknowledges a court could conclude liquidation should have been initiated. Sponsor compensation includes 235,500 Class A shares and 47,100 underlying shares from Private Placement Units, with convertible notes bearing 6-10% interest.

• · November 2025 and December 2025 extension payments were not timely deposited; November payment made January 28, 2026 (after cure period expired January 6, 2026), December payment made February 13, 2026 (after cure period).
• · January 2026 extension payment was made on February 13, 2026, within the applicable cure period.
• · Sponsor waived claims to Trust Account funds for unpaid convertible note amounts if business combination not completed.
• · Convertible notes are unsecured, bear interest at 6% (June) and 10% (others), and are convertible at $1.00 per share.
• · No formal board meeting was convened to address liquidation, but Black Hawk considered factors including full extension payments and fiduciary duties.

22-09-2026

Central Garden & Pet Company announced the retirement of John D. Walker as President, Garden Consumer Products, effective September 26, 2026. The filing does not disclose a successor or any financial impact.

• · Retirement effective September 26, 2026.
• · No successor named in the filing.
• · Filing made under Item 5.02 (Departure of Directors or Certain Officers).

22-09-2026

Blue Acquisition Corp. entered into the Sixth Amendment to its Business Combination Agreement with Blockfusion Digital Infrastructure, Inc., revising earnout terms to a maximum of 15,000,000 Earnout Shares and adjusting price thresholds to $13.00, $15.00, and $17.00 per share. The amendment also addresses the CoreWeave Warrant, which will be cancelled and replaced with a Pubco warrant for 2,870,813 shares at $7.4643 per share. The transaction remains subject to shareholder approval and other closing conditions.

• · The Sixth Amendment was entered into on September 21, 2026.
• · Earnout Shares are issuable upon satisfaction of post-closing trading price conditions based on common stock VWAPs measured over 20 of 30 trading days.
• · One-third of Earnout Shares will be delivered upon achievement of each price threshold ($13.00, $15.00, $17.00).
• · The CoreWeave Warrant was issued on September 4, 2026.
• · The replacement Pubco warrant has an initial exercise price of $7.4643 per share, subject to adjustment.
• · The BCA has been amended six times since its original execution on November 19, 2025.
• · The transaction is a de-SPAC business combination where Blue and Blockfusion will become wholly-owned subsidiaries of Pubco.
• · A registration statement on Form S-4 has been filed with the SEC, including a preliminary proxy statement/prospectus.

22-09-2026

Digital Currency X Technology Inc. (formerly Chijet Motor Company, Inc.) completed a registered direct offering on September 21, 2026, raising gross proceeds of approximately US$5.0 million (US$5,000,001.30) through the sale of 23,809,530 Class A ordinary shares at US$0.21 per share, along with Series A and Series B warrants. The company intends to use net proceeds for working capital, digital asset/cryptocurrency treasury operations, and director and officer insurance. However, the offering was priced at a significant discount to the prior market price, and the company's financial performance was not disclosed in this filing, leaving the impact on existing shareholders unclear.

• · The offering was priced on September 18, 2026, and closed on September 21, 2026.
• · The company entered into lock-up agreements with directors, officers, and 5%+ shareholders, restricting disposal of shares for 90 days after the closing date.
• · The Series A Warrants are exercisable immediately for five years, while Series B Warrants are exercisable for 30 days from issuance.
• · The offering was made under the company's Form F-3 registration statement (File No. 333-281314), initially filed August 13, 2024 and declared effective August 16, 2024.
• · The company agreed to a 30-day restriction on issuing new shares or filing registration statements (with limited exceptions) after the offering date.
• · The company's name change from Chijet Motor Company, Inc. to Digital Currency X Technology Inc. is reflected in the filing.
• · The company plans to use proceeds for digital asset and cryptocurrency treasury operations, including acquisition, custody, holding, staking, and management.

22-09-2026

Metagenomi Therapeutics, Inc. filed an 8-K on September 22, 2026, furnishing its September 2026 corporate presentation under Regulation FD. The filing is a routine disclosure of investor materials and does not contain any financial results or material operational updates.

• · The corporate presentation is dated September 2026 and furnished as Exhibit 99.1.
• · The filing is furnished, not filed, under the Exchange Act, limiting liability for forward-looking statements.
• · Metagenomi is an emerging growth company and has elected not to use the extended transition period for complying with new accounting standards.

22-09-2026

Elemental Royalty Corporation filed a Form 6-K with the SEC on September 22, 2026, for the month of September 2026, attaching a Material Change Report dated September 21, 2026. The filing is a routine foreign issuer report and does not contain any financial results or quantitative data.

• · The filing is a Form 6-K under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
• · The registrant files annual reports under Form 40-F.
• · The Material Change Report (Exhibit 99.1) is dated September 21, 2026, but its content is not included in this filing.

22-09-2026

Stewards Inc. (SWRD) entered Amendment No. 2 to its Promissory Note with FAVO Holdings, LLC, extending the maturity of a $1.6M final installment from September 1, 2026 to October 15, 2026. The company received a limited waiver of a 15% default interest rate through the extension period, with interest continuing at 10% per annum. This debt restructuring indicates the company was unable to meet its original payment obligations, though it avoids immediate default and provides a short-term liquidity bridge.

• · The Final Installment was originally due on September 1, 2026 and remained outstanding, prompting the extension.
• · The limited waiver of the 15% default interest rate is conditional; if payment is not made by October 15, 2026, the default rate is reinstated retroactively.
• · The company represents that after giving effect to this amendment, no Event of Default is continuing.
• · The amendment is governed by Nevada law with exclusive venue in Clark County, Nevada.
• · The company was formerly known as Favo Capital, Inc. and is a Nevada corporation.

22-09-2026

Banco Santander (Brasil) S.A. announced that its parent, Banco Santander, S.A., has filed key documents with Brazilian and U.S. regulators to proceed with exchange offers to acquire all outstanding shares of Santander Brasil. The filings include a Form F-4 registration statement with the SEC and requests to register Banco Santander as a foreign issuer and its BDR program with the CVM and B3. The transaction is progressing through regulatory stages, with appraisal reports received from UBS BB; however, the Form F-4 has not yet been declared effective by the SEC, and the offer remains subject to conditions and regulatory approvals.

• · The Form F-4 filed with the SEC has not yet been declared effective.
• · Filings made on September 22, 2026 include registration requests for Banco Santander as a foreign issuer (category A) and its BDR program with the CVM, admission to trade on B3, and registration of the Brazilian Exchange Offer.
• · Appraisal report prepared by UBS BB was made available simultaneously via CVM’s and B3’s IPE System and the company’s website.
• · The exchange offers are part of a transaction first announced on July 30, 2026.

22-09-2026

News Corp filed an 8-K on September 22, 2026, disclosing its daily ASX repurchase program transactions via exhibits 99.1 and 99.2. The company is authorized to repurchase up to $1 billion in aggregate of its Class A and Class B common stock. The filing includes forward-looking statements and does not contain new financial results or material operational updates.

• · The repurchase program authorizes up to $1 billion in aggregate for Class A and Class B common stock.
• · Disclosures were provided to the Australian Securities Exchange on the dates noted in Exhibits 99.1 and 99.2.
• · The filing includes forward-looking statements under the Private Securities Litigation Reform Act of 1995.
• · The company expressly disclaims any obligation to update forward-looking statements except as required by law.

22-09-2026

TC Energy announced the sale of its Guadalajara-Manzanillo Pipeline in Mexico to affiliates of ESENTIA Energy Development for gross cash proceeds of approximately $560 million (US$400 million). The transaction is expected to close in the first half of 2027 and reflects TC Energy's portfolio optimization strategy, with proceeds to be redeployed toward high-growth opportunities in North America. Following the sale, TC Energy will retain its broader Mexico natural gas pipeline network, including approximately 3,300 km of pipeline and 8.7 Bcf/d of installed capacity.

• · TC Energy has over 30 years of history in Mexico and is the largest Canadian investor in the country.
• · The pipeline connects imported LNG supply near Manzanillo and continental gas supply near Guadalajara to power plants and industrial customers in Colima and Jalisco.
• · TC Energy moves more than 30% of the natural gas used across North America daily.
• · The company's common shares trade on TSX and NYSE under symbol TRP.

22-09-2026

Grupo Aeromexico filed a Form 6-K on September 22, 2026, attaching a press release dated September 18, 2026, regarding unusual movements in the trading price of its shares. The filing does not disclose any specific financial figures, operational metrics, or underlying reasons for the price movements. No positive or negative performance data is provided, and the filing is purely a regulatory disclosure of unusual trading activity.

• · Press release titled 'Unusual Movements in the Trading Price of the Shares Representing the Company’s Capital Stock' was issued on September 18, 2026.
• · The filing is furnished under Form 6-K and does not contain any financial results or material operational changes.

22-09-2026

Bridgeline Digital held its 2026 Annual Meeting on September 17, 2026, with 54.0% of eligible shares represented. Stockholders elected Brandon Ross as a director for a three-year term, approved executive compensation on an advisory basis, and ratified PKF O'Connor Davies as independent auditor. All proposals passed, but the director election and say-on-pay received significant broker non-votes, indicating a portion of shares were not voted on those items.

• · Director Brandon Ross received 2,858,286 votes for and 41,881 withheld, with 3,910,090 broker non-votes.
• · Say-on-pay proposal received 2,597,331 for, 295,616 against, and 7,220 abstentions, with 3,910,090 broker non-votes.
• · Ratification of PKF O'Connor Davies received 6,783,554 for, 22,644 against, and 4,059 abstentions, with no broker non-votes.
• · The meeting was held on September 17, 2026, and the 8-K was filed on September 22, 2026.

22-09-2026

Innovative Advisory Group, LLC reported its Q1 2026 13F holdings, disclosing $121.75 million in total assets under management across 31 equity positions, as of March 31, 2026. The largest holdings include SPDR S&P 500 ETF Trust ($7.17M), Apple Inc. ($13.9M), and Bitwise Bitcoin ETF ($11.85M), indicating a strong tilt toward large-cap equities and crypto-related ETFs. No period-over-period comparisons are available in this initial filing.

• · Filing includes 13 crypto-related holdings (Bitcoin ETFs, Ethereum ETFs, Grayscale trusts) representing significant allocation to digital assets.
• · Notable put option positions include SPDR S&P 500 ETF (5,001 shares), iShares 20+ Year Treasury Bond ETF (2,092 calls), and Strategy Inc (5,100 puts).
• · Holdings show exposure to precious metals via SPDR Gold Trust ($3.43M) and iShares Silver Trust ($1.04M).
• · Energy sector exposure includes United States Oil Fund ($1.69M) and Select Sector SPDR Energy ETF ($2.18M).
• · No period-over-period comparison is possible as this appears to be the firm’s initial 13F filing.

22-09-2026

Sun Life Financial Inc. filed a Form 6-K with the SEC for September 2026, which includes a news release dated September 21, 2026, as Exhibit 99.1. The specific content of the news release is not provided in the filing.

• · Filing type: Form 6-K
• · Filing date: September 22, 2026
• · Commission file number: 001-15014
• · Registrant address: 1 York Street, 31st Floor, Toronto, Ontario, M5J 0B6

22-09-2026

Eldorado Gold Corporation filed a Form 6-K with the SEC for September 2026, attaching a news release dated September 21, 2026. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates beyond the attached press release.

• · The filing is a Form 6-K for the month of September 2026.
• · The attached exhibit is a news release dated September 21, 2026.
• · The registrant files annual reports under Form 40-F (check mark indicates Form 40-F).

22-09-2026

ServisFirst Bancshares, Inc. announced a quarterly cash dividend of $0.19 per share, payable on October 9, 2026, to stockholders of record as of October 1, 2026. The dividend declaration reflects a routine capital return to shareholders. No period-over-period comparisons or other financial metrics were provided in this filing.

• · Dividend payable on October 9, 2026
• · Record date: October 1, 2026
• · No prior dividend amount or comparison provided in this filing

22-09-2026

Cybin Inc. filed a Form 6-K with the SEC on September 22, 2026, attaching a news release dated September 21, 2026. The filing is a routine foreign issuer report and does not contain any financial results, material transactions, or regulatory actions. No quantitative data or period-over-period comparisons are provided.

• · The filing is a Form 6-K for the month of September 2026.
• · The attached exhibit is a news release dated September 21, 2026.
• · The company's principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.

22-09-2026

Nuburu, Inc. reported an amended 10-Q for the quarter ended June 30, 2026, showing a net loss of $5.7M for the three months (improved from $12.2M loss in the prior year) and $6.1M for the six months (improved from $28.8M loss). Revenue was $524,927 for the quarter, up from nil in the prior year, but cash and cash equivalents fell sharply to $1.6M from $25.5M at the start of the period, reflecting significant cash outflows from operations and investing activities. The company also recognized a $10.4M reclassification of convertible preferred stock from mezzanine equity to liability, and total stockholders' equity turned positive to $10.1M from a deficit of $15.2M.

• · Revenue for the six months ended June 30, 2026 was $73,322 from related parties, compared to nil in the prior year.
• · Change in fair value of warrant liabilities was a gain of $12,225,675 for the six months ended June 30, 2026, versus a loss of $110,314 in the prior year.
• · Change in fair value of debt was a gain of $8,672,492 for the six months, versus a loss of $1,166,373 in the prior year.
• · Interest expense recognized on remeasurement of preferred stock liability was nil for the six months ended June 30, 2026, versus $10,398,050 in the prior year.
• · Cash paid for acquisition of controlling financial interest in Orbit was $540,915, and for Lyocon Acquisition was $749,905 during the six months ended June 30, 2026.
• · The company issued a Tekne Subordinated Convertible Note of $928,000 during the six months ended June 30, 2026.
• · Total current assets decreased to $31,956,562 as of June 30, 2026, from $45,784,559 as of December 31, 2025.
• · Current portion of debt increased to $30,785,850 as of June 30, 2026, from $25,874,146 as of December 31, 2025.

22-09-2026

Sigma Lithium Corporation filed a Form 6-K with the SEC on September 22, 2026, attaching a press release dated September 21, 2026. The filing is a routine foreign issuer report for the month of September 2026, signed by CEO Ana Cristina Cabral. No financial results or material operational changes are disclosed in the filing itself.

• · Filing is a Form 6-K (foreign private issuer report) for September 2026.
• · The attached press release is dated September 21, 2026, but its content is not included in the filing excerpt.
• · The company's principal executive office is at 181 Bay Street, Suite 4400, Toronto, Ontario, Canada.
• · The registrant files annual reports under Form 40-F.

22-09-2026

American Battery Technology Company filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders to be held virtually on November 12, 2026. Shareholders will vote on five proposals: election of five directors, ratification of KPMG LLP as auditor, a non-binding advisory vote on executive compensation (Say-on-Pay), approval of the 2026 Equity Incentive Plan, and approval of adjournment if needed. The Board recommends a vote FOR all proposals.

• · Annual Meeting will be held virtually at www.virtualshareholdermeeting.com/ABTC2026 on November 12, 2026 at 12:00 p.m. Pacific Time.
• · Record Date for voting is September 14, 2026.
• · Quorum requirement is at least 33 1/3% of outstanding shares.
• · Proxy materials first made available on or about September 25, 2026.
• · Five directors are to be elected to the Board.

22-09-2026

Brunswick Corporation announced a leadership transition: CEO and Executive Chairman David Foulkes will retire at the end of 2026, with Aine Denari, currently EVP and President of Navico Group and CTO, appointed CEO effective January 1, 2027. David Everitt, Lead Independent Director, will become Non-Executive Chairman. The company highlighted strong momentum and a robust succession plan, but the announcement includes forward-looking risk factors and no financial results.

• · David Foulkes has served as CEO since January 2019 and Chairman since February 2025, with a two-decade career at Brunswick.
• · Aine Denari joined Brunswick in 2020 as EVP and President of Brunswick Boat Group.
• · Denari holds advanced degrees from Stanford, Northwestern, Purdue, University of Detroit Mercy, and University College Dublin.
• · Brunswick has more than 60 industry-leading brands.
• · The transition is effective January 1, 2027, with Foulkes retiring at the end of 2026.

22-09-2026

Director Dovev Gad sold 4,260 Ordinary share at $8.52 (~$36.3K). Dovev Gad holds 500 shares after the transaction.

• · Director Dovev Gad exercised/converted 2,945 Ordinary share at $5.89 (~$17.3K)
• · Director Dovev Gad sold 4,260 Ordinary share at $8.52 (~$36.3K)
• · Director Dovev Gad exercised/converted 500 Employee Stock Option